Variable Clinical Classifications and Diagnostic Coding Systems of Colorectal Neuroendocrine Tumor

다국어 초록 (Multilingual Abstract)

The incidence of colorectal carcinoid tumor is recently increasing as screening colonoscopy increased. Traditional carcinoid tumor had been known as low grade, malignant neuroendocrine cell orign tumor. In 2000, World Health Organization (WHO) suggested that carcinoid was called well-differentiated neuroendocrine tumor (NET). It recently updated in 2010 by WHO; according to the differentiation and malignant potential, NET classified with NET Grade 1, Grade 2, and neuroendocrine carcinoma.
They suggested that NET had malignant potential in accordance with histopathologic characteristics. Therefore, WHO recommended the behavior code of NET as malignant. However, European Neuroendocrine Tumor Society (ENETS) proposed the behavior of NET to four grades based on the histopathologic features; benign, benign or low grade malignant, low grade malignant, and high grade malignant. Also, American Joint Committee on Cancer (AJCC) suggested that topography codes of NET were defined as malignant. Korean Standard Classification of Diseases (KCD) described the different codings of carcinoid (NET). The discrepancies of behavior code or coding system exist among WHO, ENETS, AJCC and KCD. Also, there were differences in the perception for topographic coding system between clinicians and pathologists. NETs of colorectum were reported with the variable clinical characteristics (especially, metastasis) and long term prognosis from many studies. Especially, risk of metastasis and long term prognosis of small sized NET (<1 cm) had some discrepancies and should be investigated prospectively.
Therefore, the consensus about topographic codes of NET should be needed with multidisplinary approach among gastroenterologists,pathologists and surgeons. (Intest Res 2013;11:14-22)

참고문헌 (Reference)

1 조미연, "병리의사를 위한 소화기계 암등록에 대한 제안(Ⅰ)" 대한병리학회 42 (42): 140-150, 2008

2 Bosman F, "WHO classification of tumours of the digestive system" IARC 2010

3 Klöppel G, "The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification" 1014 : 13-27, 2004

4 Rindi G, "TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system" 451 : 757-762, 2007

5 Klöppel G, "Sitespecific biology and pathology of gastroenteropancreatic neuroendocrine tumors" 451 (451): S9-S27, 2007

6 Läuffer JM, "Review article: current status of gastrointestinal carcinoids" 13 : 271-287, 1999

7 Naunheim KS, "Rectal carcinoid tumors-- treatment and prognosis" 94 : 670-676, 1983

8 Washington MK, "Protocol for the examination of specimens from patients with neuroendocrine tumors(carcinoid tumors)of the colon and rectum" 134 : 176-180, 2010

9 Klimstra DS, "Pathology reporting of neuroendocrine tumors : application of the Delphic consensus process to the development of a minimum pathology data set" 34 : 300-313, 2010

10 Hamilton SR, "Pathology and genetics of tumours of the digestive system" IARC 2000

11 Clark OH, "NCCN neuroendocrine tumors panel members. NCCN clinical practice guidelines in oncology: neuroendocrine tumors" 7 : 712-747, 2009

12 Fujimoto Y, "Lymph-node metastases in rectal carcinoids" 395 : 139-142, 2010

13 Statistics Korea, "Korean standard classification of dieases and causes of death 2010"

14 Konishi T, "Japanese Society for Cancer of the Colon and Rectum. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years" 56 : 863-868, 2007

15 Fritz A, "International classification of diseases for oncology (ICD-O)" World Health Organization 2000

16 Kobayashi K, "Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography" 48 : 285-291, 2005

17 Plöckinger U, "Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS)" 80 : 394-424, 2004

18 Grabowski P, "Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum" 441 : 256-263, 2002

19 Soga J, "Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases" 103 : 1587-1595, 2005

20 Park CH, "Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread" 43 : 790-795, 2011

21 Ramage JK, "Consensus guidelines for the management of patients with digestive neuroendocrine tumours: welldifferentiated colon and rectum tumour/carcinoma" 87 : 31-39, 2008

22 Tsukamoto S, "Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors" 23 : 1109-1113, 2008

23 대장내시경연구회, "Clinical Characteristics of Colorectal Carcinoid Tumors" 대한대장항문학회 27 (27): 17-20, 2011

24 Van Eeden S, "Classification of low-grade neuroendocrine tumors of midgut and unknown origin" 33 : 1126-1132, 2002

25 Shields CJ, "Carcinoid tumors of the rectum : a multi-institutional international collaboration" 252 : 750-755, 2010

26 Fahy BN, "Carcinoid of the rectum risk stratification(CaRRs) : a strategy for preoperative outcome assessment" 14 : 1735-1743, 2007

27 Chetty R, "An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology" 132 : 1285-1289, 2008

28 Edge SB, "AJCC cancer staging manual" Springer 2009

29 Li AF, "A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies" 112 : 274-283, 2008